Health Care & Life Sciences » Biotechnology | CellCyte Genetics Corp.

CellCyte Genetics Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2009
2010
2011
2012
2013
Cash & Short Term Investments
7.30
-
-
-
-
Total Accounts Receivable
25.90
-
-
-
-
Other Current Assets
6.90
-
-
9.40
9.00
Total Current Assets
40.10
10.10
8.70
9.40
9.00
Net Property, Plant & Equipment
137.80
15.20
7.00
-
-
Intangible Assets
38.70
31.20
23.70
16.20
-
Total Assets
216.60
56.50
39.40
25.60
9.00
ST Debt & Current Portion LT Debt
29.80
33.00
428.20
2.40
2.70
Accounts Payable
644.70
662.80
597.20
73.00
125.50
Other Current Liabilities
160.00
221.00
232.30
259.60
223.10
Total Current Liabilities
834.50
916.70
1,257.80
335.00
351.30
Long-Term Debt
254.30
273.50
23.20
346.40
477.50
Total Liabilities
1,088.80
1,190.30
1,281.00
681.40
828.80
Common Equity (Total)
872.20
1,133.80
1,241.60
655.80
819.80
Total Shareholders' Equity
872.20
1,133.80
1,241.60
655.80
819.80
Total Equity
872.20
1,133.80
1,241.60
655.80
819.80
Liabilities & Shareholders' Equity
216.60
56.50
39.40
25.60
9.00

About CellCyte Genetics

View Profile
Address
14205 SE 36th Street
Bellevue Washington 98006
United States
Employees -
Website mailto:[email protected]
Updated 09/14/2018
CellCyte Genetics Corp. is a biotechnology development stage company, which is involved in research and development of medical devices for cell expansion and maintenance. The company was founded on March 9, 2004 and is headquartered in Bellevue, WA. .